Policymakers should break with drug and biotech norms and apply risk-based portfolio simulations to understand the global portfolio of COVID-19 vaccines.
Jack Scannell
Advertisement
Articles by Jack Scannell
Advertisement
Latest Updated Articles
COVID-19 Vaccines: Tool to Predict and Manage Global Portfolio Productivity and RiskPublished: April 23rd 2020 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NIH Implements Contingency Plan as Government Shutdown Impacts Research Funding
2
Focusing on Site Needs and Challenges: Quick Tips for Sponsors/CROs
3
Overcoming Recruitment and Retention Barriers in Alzheimer’s and Dementia Studies
4
AI Everywhere: Architecting the Future of Clinical Trials
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
